SYLVIA SWEATT: Open Payments
NPI 1245237452 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,630 in 176 payments from 26 companies in 2025. Trend: 2023 $2,323 · 2024 $2,466 · 2025 $2,630
Food & beverage: $2,630
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $406 |
| Novo Nordisk Inc | 21 | $292 |
| AstraZeneca Pharmaceuticals LP | 4 | $232 |
| PFIZER INC. | 21 | $221 |
| Lilly USA, LLC | 13 | $209 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $172 |
| Lundbeck LLC | 11 | $166 |
| Axsome Therapeutics, Inc. | 12 | $155 |
| Amgen Inc. | 13 | $145 |
| GlaxoSmithKline, LLC. | 4 | $81 |
Products named: UBRELVY, REXULTI, AIRSUPRA, CAPLYTA, NURTEC ODT, JARDIANCE, Ozempic, Wegovy.
Industry payments across KY — which companies pay providers there.
